# Marcus Tran, Head of RevOps at Fieldpath — read of Stripe Health Monitor, May 24 2026 > 9 years in RevOps, currently managing billing ops and retention reporting for a 62-person B2B SaaS out of Austin. We process about $340K MRR through Stripe. I coach my 8-year-old's YMCA soccer team Saturday mornings, which means I do all my tool research Thursday nights after 9. ## How I got here Our CFO pulled me into a Slack thread two weeks ago about $18K in failed payments last quarter. She wanted to know what we were doing about involuntary churn. Honest answer: Churn Buster is set up but I haven't touched the sequences in eight months. So Thursday I Googled "stripe dunning recovery comparison 2026" and clicked the fourth result. This page was not the fourth result. I think I wandered here from a Hacker News comment or maybe a tweet someone screenshotted. I don't actually remember clicking. ## What I clicked first "Catch failing subscriptions before they churn." Fine. That's the job. I read on. The feature table looked like every other tool in this space: ML churn prediction, smart dunning, health scoring, webhooks. I've seen this exact list from Churn Buster, Stunning, Paddle Retain, and three others. Then I hit the number "Recover 15-25% of failed payments without manual work" and I stopped. Not because that's impressive. Because that's exactly the range every one of these tools claims and none of them have ever published the denominator. ## Where I paused "Honest disclosure: we don't have live customers on this idea yet." I read that three times. Not because I was impressed by the honesty, but because I suddenly realized I had no idea what I was actually reading. I came here looking for a SaaS tool I could plug into Stripe. This is not that. This is a strategy dossier you can buy so you can GO BUILD the tool I was looking for. That's a real bait-and-switch, not intentionally, but the headline "Catch failing subscriptions before they churn" reads like a product pitch. It's actually a founder pitch deck for an operator who wants to enter this space. ## What I distrusted The Fermi math: "$-13,100 Year-1 take-home." They're telling me this idea loses money in year one and they're still selling a package to build it. I respect that they published the number. I don't respect that it doesn't slow down the page's energy at all. It's just there in a table next to "1 in 8 meaningful-success odds" like that's normal. The score section also says "financial upside: 1/10" with a 68/100 overall and somehow frames this as a product worth adopting. That framing doesn't hold together. Also: "We shipped the strategy package; you ship the customer conversations." That sentence is doing a lot of work to explain why there's no traction, no customer quotes, no MRR numbers, no canceled-churn cohort data. Nothing. Just Fermi estimates and a caveat. ## What would convince me Nothing would convince me here because I am not the buyer for this. I'm the ICP for the product this page is ABOUT, not the product this page IS. If I were evaluating this as an operator thinking about building a churn recovery SaaS, I'd want to see one real customer story from someone who used the dossier to build and ship something. Not a testimonial. A before/after: what did the dossier contain, what did the operator actually build, what happened. One is worth more than all the Fermi math on the page. ## What I'd ask in an email reply 1. Has anyone actually bought the $99 tier and shipped a working product from it? If yes, can I talk to them for 15 minutes? 2. The churn prediction feature assumes usage pattern data. Where is that data supposed to come from if my SaaS doesn't already have usage instrumentation? 3. Why is financial upside rated 1/10 but you're still recommending someone spend time and money building this? ## Verdict: dismissive This page found the wrong person. The RevOps lead with a Stripe churn problem clicks this headline thinking it's a tool and leaves 45 seconds later when they figure out it's a blueprint for someone else to go build that tool. That's a positioning problem, not a product problem. The underneath idea might be fine. The page is pointed at the wrong person. --- *Memo by skeptic persona, generated 2026-05-24T21:14:00. Studio breaks own self-grading loop.*